4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-23-032250
Chief Medical Officer gave up 2,527 shares (to pay taxes)
- Chief Medical Officer acquired 6,938 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Morrow Phuong Khanh Chief Medical Officer | 2023-05-23 | Option exercise | +6,938 | 6,938 | D | ||
| Morrow Phuong Khanh Chief Medical Officer | 2023-05-24 | Shares withheld for taxes | −2,527 | $65.91 | $166,555 | 4,411 | D |
| Derivatives | |||||||
| Morrow Phuong Khanh Chief Medical Officer | 2023-05-23 | Option exercise · Restricted Stock Units | +6,938 | 20,812 | D | ||
Loading xslF345X04/doc4.xml…